-The Hindu The Supreme Court's reasoning in the Devinder Pal Singh Bhullar case reveals an unfortunate determination to sanction judicial execution because it involved a terrorist offence. If there is one principle that emerges from the judgment of Justice G.S. Singhvi and Justice S.J. Mukhopadhaya, it is that prolonged delay in disposal of a mercy petition, until now considered a possible constitutional limitation on carrying out an execution, will not be...
More »SEARCH RESULT
Total Matching Records found : 300
Rajiv assassin’s RTI query: Why my plea was rejected? -Arun Janardhanan
-The Times of India CHENNAI: One of the three convicts on death row for the assassination of Rajiv Gandhi, AG Perarivalan, will on Monday be on a videoconference with Central Information Commissioner Satyananda Mishra on a complaint against Rashtrapati Bhavan and the ministry of home affairs on a petition seeking to know why his mercy plea was rejected in August 2011. A notification on the videoconference was fixed three days ago...
More »World abolishing death penalty, but executions on rise in India -Himanshi Dhawan
-The Times of India Fewer countries are carrying out executions than a decade ago, but India along with nations like Gambia, Pakistan and Japan bucked the trend to resume handing out death penalties. An Amnesty International report says that 21 countries executed convicts last year as compared to 28 in 2003. But there is greater concern that Indian courts had meted out at least 78 Death sentences with more than 400 estimated...
More »Don't keep people on death row in limbo, CJI Altamas Kabir tells govt -Pradeep Thakur
-The Times of India Asking the government not to keep mercy petitions of death row convicts pending for a long time, Chief Justice of India Altamas Kabir on Sunday said execution of death penalty should not be delayed. He also faulted the government for not informing Parliament attack convict Afzal Guru's family members before he was hanged. "If a death penalty is to be awarded and it is there under the system,...
More »More battles in store-Aarti Dhar
-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...
More »
